Chemotargets Announces First AI-Designed Drug for Huntington’s Disease to Enter Clinical Trials

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

This is a Biotech company founded in 2006 by Dr. Jordi Mestres as a spin-off from the Hospital del Mar Medical Research Institute (IMIM)

Read more

Synthesisi of Pyrazoles from Acetophenones in Flow

by Galchimia

Flow Chemistry is a key enabling technology that has proven to be particularly advantageous for certain syntheses. Its inherent characteristics offer a wide range of benefits: reactions cannot only be...

Read more

SOM Biotech at Chiba Healthcare Business Forum 2021

by Som Biotech

SOM Biotech will attend the “Chiba Global Healthcare Business Forum 2021” on February 3rd – 4th, which will take place digitally due to the pandemic situation.

Read more

SOM Biotech keynote speaker at the Drug Discovery Innovation Programme Virtual Event 2020

by Som Biotech

SOM Biotech announces its participation at the Drug Discovery Innovation Programme event 2020, being held virtually on November 17th. The conference will be chaired by Kevin McAllister, PhD, MBA Chief...

Read more

SOM Biotech attended the BIO International Convention 2020

by Som Biotech

The virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportuni...

Read more

An open-access tool to accelerate drug discovery

by IRB Barcelona - Instituto de Investigación Biomédica

The Chemical Checker provides processed, harmonized and ready-to-use bioactivity information on more than 1M small molecules. The tool, developed by the Structural Bioinformatics and Network Biology l...

Read more

ZeClinics joins the drug discovery and delivery network for oncology and eye therapeutics (3D-NEONET)

by ZeClinics

The consortium is bringing together a unique group of microbiologists, cancer biologists, chemists, material scientists, mechanical engineers, ocular pharmacologists, geneticists and toxicologists fro...

Read more

La mejora en el diagnóstico del Alzheimer permite realizar investigación en fases más precoces de la enfermedad

by Hospital Universitari de Bellvitge

El Dr. Ramon Reñé, responsable de la Unidad Funcional de Demencias del Hospital Universitario de Bellvitge (UFD-HUB), destaca que “la espectacular mejora en el diagnóstico precoz a la que hemos a...

Read more

Fundación MEDINA presents during the symposium FiAAD the results of a research focused on the identification of new antibiotics and antiinfective treatments

by MEDINA

The symposium is organized jointly by the Medicinal Chemistry Section of the Swedish Pharmaceutical Society and ENABLE, one of the projects in the Innovative Medicines Initiative ND4BB in which MEDINA...

Read more

Launch of Nostrum BioDiscovery, a spin-off that applies supercomputing to speed up drug discovery

by IRB Barcelona - Instituto de Investigación Biomédica

Nostrum BioDiscovery has come about from the combined efforts of IRB Barcelona and the BSC-CNS—two research centres of excellence in Barcelona—with the participation of the University of Barcelona...

Read more

Cancer drug could treat blood vessel deformities

by IBEC - Institut de Bioenginyeria de Catalunya

A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice ...

Read more

New anti-carcinogenic compounds with low toxicity that may decrease the side effects of chemotherapy

by Universitat Jaume I

The designed compounds have particularly high therapeutic effects on tumour cells of breast and colon and can be the basis for the development of oncological drugs of low toxicity and high selectivity...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream